List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 44 studies with search of: "Flushing"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Alternative Options to Minimize Niacin-Induced Flushing
Conditions: Hypercholesterolemia;   Flushing
Interventions: Other: Apple pectin;   Drug: Aspirin 325 mg;   Other: Apple pectin 2000 mg + aspirin 325 mg;   Other: Placebo
2 Completed Effect of MK0524A on Flushing Caused by Niacin
Condition: Flushing
Interventions: Drug: MK0524A, /Duration of Treatment : 4 Weeks;   Drug: Comparator : niacin /Duration of Treatment : 1 Weeks
3 Completed Endpoint Validation Study
Condition: Flushing
Interventions: Drug: MK0524A, /Duration of Treatment : 8 Weeks;   Drug: Comparator : placebo (unspecified) /Duration of Treatment : 8 Weeks
4 Completed MK0524A Phase IIb Study
Condition: Flushing
Interventions: Drug: Comparator: niacin / Duration of Treatment: 17 Weeks;   Drug: MK0524A, niacin (+) laropiprant / Duration of Treatment: 17 Weeks;   Drug: Comparator: placebo (unspecified) / Duration of Treatment: 17 Weeks
5 Completed Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
Condition: Hot Flushes
Intervention: Drug: 2.2mg 17 Beta-estradiol/0.69mg levonorgestrel combination transdermal patch and a 1mg 17 Beta-estradiol transdermal patch
6 Completed Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Condition: Hot Flushes, Menopause, Postmenopause
Interventions: Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT);   Drug: Esterified Estrogens (EE) and Methyltestosterone (MT)
7 Completed A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
Condition: Healthy Subjects
Intervention: Drug: GSK256073A tablets + IR niacin tablets
8 Completed Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
Condition: Dyslipidemia
Interventions: Drug: ABT-919;   Drug: ASA;   Drug: niacin placebo;   Drug: ASA placebo
9 Completed A Placebo-Controlled Prospective Study to Evaluate Flushing in Subjects Administered Niaspan® Plus Aspirin for Six Weeks
Condition: Dyslipidemia
Interventions: Drug: Niaspan plus aspirin;   Drug: Niaspan plus aspirin placebo;   Drug: Niaspan placebo/aspirin placebo
10 Completed A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters
Conditions: Catheters, Indwelling;   Thrombosis
Intervention:
11 Completed Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis;   Anaphylaxis
Intervention:
12 Active, not recruiting Understanding Experimentally Induced Hot Flushes
Condition: Hot Flashes
Interventions: Drug: Leuprolide acetate (Lupron);   Procedure: PET scan;   Procedure: MRI scan
13 Completed Acupuncture for Hot Flushes in Menopause
Conditions: Menopause;   Hot Flashes
Interventions: Procedure: Traditional chinese medicine type acupuncture;   Procedure: Self Care
14 Completed Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices
Condition: Thrombosis
Intervention: Drug: Lepirudin
15 Completed Development of Active Safety Surveillance System for Traditional Chinese Medicine
Conditions: Climacteric Symptoms;   Hot Flushes and/or Sweats
Intervention: Drug: TMN-1
16 Completed Treatment of Hot Flushes in Asian Women With Ultra-Low Dose Estradiol Patch
Condition: Hot Flashes
Interventions: Drug: Menostar (estradiol transdermal delivery system);   Drug: Placebo
17 Completed ZK283197 for Treatment of Vasomotor Symptoms
Condition: Vasomotor System
Interventions: Drug: BAY86-5310 (ZK283197);   Drug: Placebo;   Drug: BAY86-5310 (ZK283197);   Drug: 17ß-estradiol
18 Not yet recruiting Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture
Conditions: Breast Cancer;   Postmenopause
Intervention: Procedure: acupuncture
19 Recruiting Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
Condition: Hot Flashes
Intervention: Drug: Gabapentin Extended Release tablets
20 Completed Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
Condition: Hot Flashes
Intervention: Drug: Gabapentin Extended Release tablets

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services